Humans are living longer than ever. But age-related diseases such as sarcopenia - the loss of muscle mass - are on the rise. Researchers in Basel say a well-known drug might help delay the aging process.
The Swiss generally live long lives. According to the most recent statistics, Swiss men live on average to the age of 81.3, and women to 85.3. But as a natural part of aging, over time people’s muscles lose tone, shrink and strength dwindles.
This condition, known as sarcopenia, affects every second or third person over 80, reducing their mobility, autonomy and quality of life. The causes of sarcopenia are diverse: from altered muscle metabolism to changes in nerves supplying muscles.
A group of scientists at the University of Basel’s BiozentrumExternal link, which has been investigating the question, has identified a key molecular ‘signature’ of sarcopenia. The team, led by Professor Markus Rüegg, have discovered that mTORC1, which acts as a sensor and controls protein synthesis in the body, also contributes to sarcopenia and its suppression with the well-known drug rapamycin slows age-related muscle wasting.
“Contrary to our expectations, the long-term mTORC1 suppression with rapamycin is overwhelmingly beneficial for skeletal muscle aging in mice, preserving muscle size and strength,” declared Daniel Ham, first author of the study.
To encourage other scientists to further investigate how gene expression in skeletal muscle changes during aging or in response to rapamycin treatment, they have created a web application, SarcoAtlasExternal link, which is supported the Centre for Scientific Computing at the University of Basel (sciCORE).
Currently, there is no effective pharmacological therapy to treat sarcopenia. But the scientists say their study gives hope that in the future it may be possible to slow down age-related muscle wasting with treatments that suppress mTORC1 and thereby extend the autonomy and life quality of elderly people.
Train vs plane: would you take a direct train between London and Geneva?
Eurostar is planning to run direct trains from Britain to Germany and Switzerland from the early 2030s. Would you favour the train over the plane? If not, why not?
Swiss voters to decide on three issues on November 30
This content was published on
Compulsory service for all, a tax on million-dollar inheritances, more indirect subsidies for media publishers: the electorate can vote on these three national issues on November 30.
Dollar falls to lowest level against franc in 14 years
This content was published on
The weakness of the dollar in recent weeks continues. The greenback hit new lows for the year against both the franc and the euro on Tuesday.
This content was published on
Swiss President Karin Keller-Sutter has met French President Emmanuel Macron to discuss the EU treaties and geopolitical challenges. US tariffs were also part of the bilateral talks.
This content was published on
Swiss moors and floodplains are in a poor state. Researchers say further efforts are needed to preserve these biotopes in the long term.
Drones banned during the three Euro games in St Gallen
This content was published on
The St. Gallen government has issued a temporary ban on flying drones around the football stadium in St. Gallen. The measure will apply on three match days of Euro 2025, which starts on Wednesday.
EU nationals come to Switzerland primarily to work
This content was published on
Given the demographic slowdown, the Swiss labour market must remain open, argues the State Secretariat for Economic Affairs (SECO) in its annual report on the free movement of people.
UN expert accuses Glencore of complicity with Israel
This content was published on
The UN Special Rapporteur on the Palestinian Territories has accused Zug-based Glencore of profiting from an Israeli economy that has become "an economy of genocide".
Swiss parliamentary commission to investigate F-35 purchase
This content was published on
The Swiss government and the other responsible authorities must once again answer critical questions about the procurement of the F-35 fighter jets.
Objections and appeals most common obstacles to residential construction projects
This content was published on
Objections and appeals are most frequently responsible for delays in new residential construction projects in Switzerland.
Swiss electricity prices predicted to fall in 2026
This content was published on
Electricity prices in 2026 are likely to be lower than this year, according to a survey. The main reason is the fall in prices on the electricity market.
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.
Read more
More
Heart disease and cancer still biggest causes of death
This content was published on
Cardiovascular disease and cancer were the two most widespread causes of death in Switzerland in 2017, new statistics have shown.
This content was published on
The latest federal health survey of people 55 and older reveals that social factors such as education influence health into old age.
You can find an overview of ongoing debates with our journalists here . Please join us!
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.